Veda soars 60% — is it too late to buy?

The relisting of Veda has seen a rush by investors to gain exposure to the company.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Credit reporting and data services company Veda (ASX: VED) is still riding high on Monday morning after seeing its share price soar 40% last Thursday when the stock first traded post-initial public offering (IPO).

Veda's IPO was priced at $1.25, however by the close of trade on Thursday the stock was trading at $1.75, providing an initial one day return of 40%. The stock price has continued to climb over Friday and today with the shares hitting a high of $2 on Monday morning and providing investors in the float with a gain (on paper at least) of 60%.

The debut and opening days of trading in Veda stock makes Veda's IPO one of the most successful out of the recent string of IPOs. Website operator Freelancer (ASX: FLN) also had a stellar initial debut — the stock price has trended down since its listing but is still up around 100% on the float price of 50 cents.

Meanwhile electronics retail Dick Smith (ASX: DSH) and television network owner Nine Entertainment (ASX: NEC), which both listed on the ASX last week at $2.20 and $2.05 respectively, have had relatively muted listings and continue to trade close to their initial float prices.

Foolish takeaway

At $2 per share, the market capitalisation of Veda is nearly $1.7 billion, plus the company carries nearly $290 million of net debt, giving the firm an enterprise value of $1.99 billion.

According to the prospectus, management is forecasting pro forma earnings before interest and tax (EBIT) of $102.4 million for the upcoming 2014 financial year. This implies an increase of 24.7% on the prior year and represents an EV to EBIT multiple of 19.4.

While Veda may be a sound business and have good growth prospects ahead of it, at a multiple of 19.4 investors who missed out on an allocation in the float would appear to be paying a very full price to purchase stock at the $2 mark.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »